Skip to main content

KLCM Advisors, Inc.

SEC CIK
0001166620
Latest filing
Aug 6, 2026

ABT holding history

Abbott Laboratories in every 13F filed by KLCM Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
8,897
Value
$807.3K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by KLCM Advisors, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,897$807.3K0.1%+6+0.1%AddedHolders
Q1 20268,891$912.8K0.1%−374−4.0%ReducedHolders
Q4 20259,265$1.16M0.1%−378−3.9%ReducedHolders
Q3 20259,643$1.29M0.1%−266−2.7%ReducedHolders
Q2 20259,909$1.35M0.1%−240−2.4%ReducedHolders
Q1 202510,149$1.35M0.2%−229−2.2%ReducedHolders
Q4 202410,378$1.17M0.1%+120+1.2%AddedHolders
Q3 202410,258$1.17M0.1%+243+2.4%AddedHolders
Q2 202410,015$1.04M0.1%+100+1.0%AddedHolders
Q1 20249,915$1.13M0.1%−80−0.8%ReducedHolders
Q4 20239,995$1.10M0.2%−476−4.5%ReducedHolders
Q3 202310,471$1.01M0.2%−63−0.6%ReducedHolders
Q2 202310,534$1.15M0.2%+977+10.2%AddedHolders
Q1 20239,557$967.8K0.2%+18+0.2%AddedHolders
Q4 20229,539$1.05M0.2%−47−0.5%ReducedHolders
Q3 20229,586$927.0K0.2%+546+6.0%AddedHolders
Q2 20229,040$982.0K0.2%+104+1.2%AddedHolders
Q1 20228,936$1.06M0.2%−57−0.6%ReducedHolders
Q4 20218,993$1.27M0.3%−390−4.2%ReducedHolders
Q3 20219,383$1.11M0.2%+10.0%AddedHolders
Q2 20219,382$1.09M0.2%+247+2.7%AddedHolders
Q1 20219,135$1.09M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.